Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC lessened its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 0.5% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,615,996 shares of the company's stock after selling 8,505 shares during the quarter. Allspring Global Investments Holdings LLC owned about 3.26% of Prestige Consumer Healthcare worth $138,539,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in PBH. Geode Capital Management LLC raised its stake in shares of Prestige Consumer Healthcare by 1.7% in the 4th quarter. Geode Capital Management LLC now owns 1,348,745 shares of the company's stock valued at $105,342,000 after acquiring an additional 21,951 shares during the period. Kayne Anderson Rudnick Investment Management LLC purchased a new position in shares of Prestige Consumer Healthcare in the 4th quarter valued at $84,932,000. Invesco Ltd. raised its stake in shares of Prestige Consumer Healthcare by 2.4% in the 4th quarter. Invesco Ltd. now owns 1,060,263 shares of the company's stock valued at $82,796,000 after acquiring an additional 24,392 shares during the period. Congress Asset Management Co. raised its stake in shares of Prestige Consumer Healthcare by 9.1% in the 1st quarter. Congress Asset Management Co. now owns 991,580 shares of the company's stock valued at $85,246,000 after acquiring an additional 82,838 shares during the period. Finally, Northern Trust Corp increased its stake in Prestige Consumer Healthcare by 10.9% during the 4th quarter. Northern Trust Corp now owns 813,076 shares of the company's stock worth $63,493,000 after buying an additional 80,055 shares during the period. Institutional investors and hedge funds own 99.95% of the company's stock.

Analyst Ratings Changes

Several equities research analysts recently issued reports on PBH shares. Royal Bank Of Canada raised shares of Prestige Consumer Healthcare to a "hold" rating in a research note on Thursday, May 8th. Wall Street Zen raised shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, May 17th. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat, Prestige Consumer Healthcare has an average rating of "Moderate Buy" and an average target price of $93.33.

Prestige Consumer Healthcare Stock Performance

Prestige Consumer Healthcare stock opened at $81.00 on Friday. Prestige Consumer Healthcare Inc. has a 12-month low of $64.94 and a 12-month high of $90.04. The company has a market capitalization of $4.00 billion, a price-to-earnings ratio of 18.88, a price-to-earnings-growth ratio of 2.44 and a beta of 0.45. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.20 and a quick ratio of 2.82. The firm's fifty day moving average price is $84.14 and its 200 day moving average price is $82.46.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.30 by $0.02. The company had revenue of $296.52 million during the quarter, compared to the consensus estimate of $289.36 million. Prestige Consumer Healthcare had a net margin of 18.86% and a return on equity of 12.87%. The company's revenue was up 7.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.02 EPS. On average, research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.